about
Multifunctional biodegradable polymer nanoparticles with uniform sizes: generation and in vitro anti-melanoma activity.Recent advances in targeted nanoparticles drug delivery to melanoma.Biodegradable polymer microcapsules fabrication through a template-free approach.Multiresponsive hydrogel photonic crystal microparticles with inverse-opal structure.Electric-Field-Assisted Assembly of Polymer-Tethered Gold Nanorods in Cylindrical Nanopores.Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response.Block Copolymer Capsules with Structure-Dependent Release Behavior.Construction of multifunctional photonic crystal microcapsules with tunable shell structures by combining microfluidic and controlled photopolymerization.Structural Transformation of Diblock Copolymer/Homopolymer Assemblies by Tuning Cylindrical Confinement and Interfacial Interactions.Encapsulation of pristine fullerene C60 within block copolymer micelles through interfacial instabilities of emulsion droplets.Uniform core-shell photonic crystal microbeads as microcarriers for optical encoding.Monodisperse PLA/PLGA nanoparticle fabrication through a surfactant-free routeROS-Inducing Micelles Sensitize Tumor-Associated Macrophages to TLR3 Stimulation for Potent ImmunotherapyOxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastasesIn Situ Photocatalysis of TiO-Porphyrin-Encapsulated Nanosystem for Highly Efficient Oxidative Damage against Hypoxic TumorsBioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal EffectSurface-Functionalized Nanoparticles as Efficient Tools in Targeted Therapy of Pregnancy Complications
P50
Q35022052-485657AD-0B87-4748-89B6-7E6EDE66B79FQ38306040-6C980143-463A-40C0-BCA8-C6EB1D61621AQ43760510-F8D27C8F-F00E-4F24-B0AB-75C5D36C123AQ43890119-4E7E7637-44AE-4A9C-BA13-EE36DB554D03Q44022791-39E30F38-274A-466C-9D20-3FB68DD452A4Q47586811-B6D4CE7C-AE8C-4FF1-8AAB-8A43D29D6027Q47730028-B9794711-7036-4823-90B0-EC99D1BBF938Q51126081-A5D12672-3257-43B4-9A1F-F8F06C56724AQ51538918-64F8DE98-A52C-40D2-B436-98816C6D5C80Q51676222-A2CEC7DF-A1B6-4947-870F-64943C3A2394Q51756674-7D5F6217-3B4B-4A90-B105-AD118671DCA5Q53441818-00559CD2-4466-4CD7-B72F-5196A80947E1Q83127586-66A21736-FA75-4929-A197-5E34CD11986FQ88399151-79BBB893-CDB4-4125-B9BA-E7897A210AD8Q89064378-79EDCC69-AF17-48DE-B3DB-F1D29425CDA9Q89971636-A2F5F1F3-D81D-4ED9-BBBB-77D85F1EAF9AQ90038052-844C700D-2498-4CB5-A411-75BD3362A690Q92210168-AD83B4CE-48D4-467C-9242-DE060FE2DAC0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ruijing Liang
@ast
Ruijing Liang
@en
Ruijing Liang
@es
Ruijing Liang
@nl
Ruijing Liang
@sl
type
label
Ruijing Liang
@ast
Ruijing Liang
@en
Ruijing Liang
@es
Ruijing Liang
@nl
Ruijing Liang
@sl
prefLabel
Ruijing Liang
@ast
Ruijing Liang
@en
Ruijing Liang
@es
Ruijing Liang
@nl
Ruijing Liang
@sl
P106
P1153
48661259600
P31
P496
0000-0003-3248-2780